Parabolic Drugs adds 15 percent capacity to its Cephalosporin facility
Parabolic Drugs Ltd., a vertically integrated API manufacturer and exporter in India, today announced the commissioning of eighth manufacturing plant at its European GMP Accredited Derabassi facility – fully dedicated for the manufacturing of latest generation Cephalosporin, both in Oral and Sterile forms.
